Literature DB >> 19166913

Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis.

A Jaferi1, V M Pickel.   

Abstract

The anxiolytic effects of opiates active at the mu-opioid receptor (mu-OR) may be ascribed, in part, to suppression of neurons that are responsive to the stress-associated peptide, corticotropin releasing factor (CRF), in the central amygdala (CeA) and bed nucleus of the stria terminalis (BNST). The corticotropin releasing factor receptor (CRFr) and mu-OR are expressed in both the CeA and BNST, but their subcellular relationship to each other is not known in either region. To address this question, we used dual electron microscopic immunolabeling of mu-OR and CRFr in the mouse lateral CeA and anterolateral BNST. Immunolabeling for each receptor was detected in the same as well as in separate somatic, dendritic and axonal profiles of neurons in each region. CRFr had a plasmalemmal or cytoplasmic distribution in many dendrites, including those co-expressing mu-OR. The co-expression of CRFr and mu-OR also was seen near excitatory-type synapses on dendritic spines. In both the CeA and BNST, over 50% of the CRFr-labeled dendritic profiles (dendrites and spines) contained immunoreactivity for the mu-OR. However, less than 25% of the dendritic profiles containing the mu-OR were labeled for CRFr in either region, suggesting that opiate activation of the mu-OR affects many neurons in addition to those responsive to CRF. The dendritic profiles containing CRFr and/or mu-OR received asymmetric, excitatory-type synapses from unlabeled or CRFr-labeled axon terminals. In contrast, the mu-OR was identified in terminals forming symmetric, inhibitory-type synapses. Thus, in both the CeA and BNST, mu-OR and CRFr have strategic locations for mediation of CRF and opioid effects on the postsynaptic excitability of single neurons, and on the respective presynaptic release of excitatory and inhibitory neurotransmitters. The commonalities in the synaptic location of both receptors in the CeA and BNST suggest that this is a fundamental cellular association of relevance to both drug addiction and stress-induced disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166913      PMCID: PMC2678868          DOI: 10.1016/j.neuroscience.2008.12.061

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  115 in total

1.  Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell.

Authors:  Karen T Delle Donne; June Chan; Helene Boudin; Didier Pélaprat; William Rostène; Virginia M Pickel
Journal:  Synapse       Date:  2004-06-01       Impact factor: 2.562

2.  Rat central amygdaloid nucleus projections to the bed nucleus of the stria terminalis.

Authors:  N Sun; L Roberts; M D Cassell
Journal:  Brain Res Bull       Date:  1991-11       Impact factor: 4.077

3.  Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex.

Authors:  M Sakanaka; T Shibasaki; K Lederis
Journal:  Brain Res       Date:  1986-09-24       Impact factor: 3.252

4.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord.

Authors:  U Arvidsson; M Riedl; S Chakrabarti; J H Lee; A H Nakano; R J Dado; H H Loh; P Y Law; M W Wessendorf; R Elde
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

5.  Endogenous opioids modulate the cardiovascular response to mental stress.

Authors:  M Morris; P Salmon; H Steinberg; E A Sykes; P Bouloux; E Newbould; L McLoughlin; G M Besser; A Grossman
Journal:  Psychoneuroendocrinology       Date:  1990       Impact factor: 4.905

6.  Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.

Authors:  R S Duman; J F Tallman; E J Nestler
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

7.  Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.

Authors:  Virgina M Pickel; Jane Chan; Christopher S Kearn; Kenneth Mackie
Journal:  J Comp Neurol       Date:  2006-03-20       Impact factor: 3.215

8.  Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala.

Authors:  Sa Li; Gilbert J Kirouac
Journal:  J Comp Neurol       Date:  2008-01-10       Impact factor: 3.215

9.  Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division.

Authors:  Nathan J Marchant; Valerie S Densmore; Peregrine B Osborne
Journal:  J Comp Neurol       Date:  2007-10-20       Impact factor: 3.215

10.  Intrinsic GABAergic neurons in the rat central extended amygdala.

Authors:  N Sun; M D Cassell
Journal:  J Comp Neurol       Date:  1993-04-15       Impact factor: 3.215

View more
  24 in total

1.  Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor.

Authors:  Azra Jaferi; Ping Zhou; Virginia M Pickel
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

2.  Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  Marc A Beckerman; Michael J Glass
Journal:  Exp Neurol       Date:  2010-10-21       Impact factor: 5.330

3.  Connectivity between the central nucleus of the amygdala and the bed nucleus of the stria terminalis in the non-human primate: neuronal tract tracing and developmental neuroimaging studies.

Authors:  Jonathan A Oler; Do P M Tromp; Andrew S Fox; Rothem Kovner; Richard J Davidson; Andrew L Alexander; Daniel R McFarlin; Rasmus M Birn; Benjamin E Berg; Danielle M deCampo; Ned H Kalin; Julie L Fudge
Journal:  Brain Struct Funct       Date:  2016-02-23       Impact factor: 3.270

Review 4.  Functional Heterogeneity in the Bed Nucleus of the Stria Terminalis.

Authors:  Nur Zeynep Gungor; Denis Paré
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

5.  Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.

Authors:  Kellie M Jaremko; Nicholas L Thompson; Beverly A S Reyes; Jay Jin; Brittany Ebersole; Christopher B Jenney; Patricia S Grigson; Robert Levenson; Wade H Berrettini; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

6.  Ultrastructural relationship between N-methyl-D-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  M J Glass; L Vanyo; L Quimson; V M Pickel
Journal:  Neuroscience       Date:  2009-07-14       Impact factor: 3.590

7.  Neuroanatomical distribution of μ-opioid receptor mRNA and binding in monogamous prairie voles (Microtus ochrogaster) and non-monogamous meadow voles (Microtus pennsylvanicus).

Authors:  K Inoue; J P Burkett; L J Young
Journal:  Neuroscience       Date:  2013-03-26       Impact factor: 3.590

8.  Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Tracey A Van Kempen; Nicholas J Justice; Teresa A Milner; Michael J Glass
Journal:  Exp Neurol       Date:  2012-10-12       Impact factor: 5.330

9.  Deletion of the NMDA-NR1 receptor subunit gene in the mouse nucleus accumbens attenuates apomorphine-induced dopamine D1 receptor trafficking and acoustic startle behavior.

Authors:  Michael J Glass; Danielle C Robinson; Elizabeth Waters; Virginia M Pickel
Journal:  Synapse       Date:  2013-03-05       Impact factor: 2.562

10.  Subcellular plasticity of the corticotropin-releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure.

Authors:  A Jaferi; D A Lane; V M Pickel
Journal:  Neuroscience       Date:  2009-06-17       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.